Skip to main content
Clinical Trials/IRCT20211230053569N1
IRCT20211230053569N1
Completed
Phase 1

Comparison of anesthetic efficacy of articaine with lidocaine as an inferior nerve blocking agent in subjects with symptomatic irreversible pulpitis

Riphah International University0 sites152 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Symptomatic irreversible pulpitis in posterior mandibular teeth.
Sponsor
Riphah International University
Enrollment
152
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Subjects of both genders (males and females), in good health, with no systemic disease that will interfere with the action of any of the anesthetic solutions being used, aged between 26 – 35 years
  • Mandibular posterior teeth requiring endodontic treatment due to symptomatic irreversible pulpitis
  • There should have been no previous attempts of endodontic therapy on that tooth
  • Positive pulp sensibility testing (cold testing)

Exclusion Criteria

  • Patients who have known allergy to amides
  • Patients taking any medication that will alter their perception of pain
  • Patients who are suffering from any heart disease, diabetes mellitus
  • Female patients who are pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials